1
|
Lam BYH, Williamson A, Finer S, Day FR, Tadross JA, Gonçalves Soares A, Wade K, Sweeney P, Bedenbaugh MN, Porter DT, Melvin A, Ellacott KLJ, Lippert RN, Buller S, Rosmaninho-Salgado J, Dowsett GKC, Ridley KE, Xu Z, Cimino I, Rimmington D, Rainbow K, Duckett K, Holmqvist S, Khan A, Dai X, Bochukova EG, Trembath RC, Martin HC, Coll AP, Rowitch DH, Wareham NJ, van Heel DA, Timpson N, Simerly RB, Ong KK, Cone RD, Langenberg C, Perry JRB, Yeo GS, O'Rahilly S. MC3R links nutritional state to childhood growth and the timing of puberty. Nature 2021; 599:436-441. [PMID: 34732894 PMCID: PMC8819628 DOI: 10.1038/s41586-021-04088-9] [Citation(s) in RCA: 44] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2020] [Accepted: 10/01/2021] [Indexed: 02/02/2023]
Abstract
The state of somatic energy stores in metazoans is communicated to the brain, which regulates key aspects of behaviour, growth, nutrient partitioning and development1. The central melanocortin system acts through melanocortin 4 receptor (MC4R) to control appetite, food intake and energy expenditure2. Here we present evidence that MC3R regulates the timing of sexual maturation, the rate of linear growth and the accrual of lean mass, which are all energy-sensitive processes. We found that humans who carry loss-of-function mutations in MC3R, including a rare homozygote individual, have a later onset of puberty. Consistent with previous findings in mice, they also had reduced linear growth, lean mass and circulating levels of IGF1. Mice lacking Mc3r had delayed sexual maturation and an insensitivity of reproductive cycle length to nutritional perturbation. The expression of Mc3r is enriched in hypothalamic neurons that control reproduction and growth, and expression increases during postnatal development in a manner that is consistent with a role in the regulation of sexual maturation. These findings suggest a bifurcating model of nutrient sensing by the central melanocortin pathway with signalling through MC4R controlling the acquisition and retention of calories, whereas signalling through MC3R primarily regulates the disposition of calories into growth, lean mass and the timing of sexual maturation.
Collapse
Affiliation(s)
- B Y H Lam
- MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- NIHR Cambridge Biomedical Research Centre, Cambridge, UK
| | - A Williamson
- MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- NIHR Cambridge Biomedical Research Centre, Cambridge, UK
- MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
| | - S Finer
- Wolfson Institute of Population Health, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
| | - F R Day
- MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
| | - J A Tadross
- MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- NIHR Cambridge Biomedical Research Centre, Cambridge, UK
- Department of Pathology, University of Cambridge, Cambridge, UK
| | - A Gonçalves Soares
- MRC Integrative Epidemiology Unit and Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
| | - K Wade
- MRC Integrative Epidemiology Unit and Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
| | - P Sweeney
- Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA
| | - M N Bedenbaugh
- Department of Molecular Physiology and Biophysics, School of Medicine, Vanderbilt University, Nashville, TN, USA
| | - D T Porter
- Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA
| | - A Melvin
- MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- NIHR Cambridge Biomedical Research Centre, Cambridge, UK
| | - K L J Ellacott
- Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Exeter, UK
| | - R N Lippert
- Department of Neurocircuit Development and Function, German Institute of Human Nutrition, Potsdam, Germany
| | - S Buller
- MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- NIHR Cambridge Biomedical Research Centre, Cambridge, UK
| | - J Rosmaninho-Salgado
- Medical Genetics Unit, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - G K C Dowsett
- MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- NIHR Cambridge Biomedical Research Centre, Cambridge, UK
| | - K E Ridley
- Department of Paediatrics, University of Cambridge, Cambridge, UK
| | - Z Xu
- Department of Paediatrics, University of Cambridge, Cambridge, UK
| | - I Cimino
- MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- NIHR Cambridge Biomedical Research Centre, Cambridge, UK
| | - D Rimmington
- MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- NIHR Cambridge Biomedical Research Centre, Cambridge, UK
| | - K Rainbow
- MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- NIHR Cambridge Biomedical Research Centre, Cambridge, UK
| | - K Duckett
- MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- NIHR Cambridge Biomedical Research Centre, Cambridge, UK
| | - S Holmqvist
- Department of Paediatrics, University of Cambridge, Cambridge, UK
| | - A Khan
- Wolfson Institute of Population Health, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
| | - X Dai
- Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK
| | - E G Bochukova
- Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK
| | - R C Trembath
- School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK
| | - H C Martin
- Wellcome Sanger Institute, Hinxton, Cambridge, UK
| | - A P Coll
- MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- NIHR Cambridge Biomedical Research Centre, Cambridge, UK
| | - D H Rowitch
- Department of Paediatrics, University of Cambridge, Cambridge, UK
| | - N J Wareham
- MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
| | - D A van Heel
- Wolfson Institute of Population Health, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
- Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK
| | - N Timpson
- MRC Integrative Epidemiology Unit and Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
| | - R B Simerly
- Department of Molecular Physiology and Biophysics, School of Medicine, Vanderbilt University, Nashville, TN, USA
| | - K K Ong
- MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- Department of Paediatrics, University of Cambridge, Cambridge, UK
| | - R D Cone
- Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA
- Department of Molecular and Integrative Physiology, School of Medicine, University of Michigan, Ann Arbor, MI, USA
| | - C Langenberg
- MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- Computational Medicine, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - J R B Perry
- MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
| | - G S Yeo
- MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- NIHR Cambridge Biomedical Research Centre, Cambridge, UK
| | - S O'Rahilly
- MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
- NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
| |
Collapse
|
2
|
Melvin A, Cowan C, Lam B, Buller S, Rainbow K, Yeo GS, O’Rahilly S. SUN-LB107 Functional Characterisation of Human Heterozygous Non-Synonymous MC3R Variants. J Endocr Soc 2020. [PMCID: PMC7209424 DOI: 10.1210/jendso/bvaa046.2097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Abstract
Background: Melanocortin 3 receptor (MC3R) is a member of the melanocortin family of G-protein coupled receptors predominantly expressed in hypothalamic tissue. Rodent models have implicated MC3R in the pathogenesis of obesity, however in humans the relationship between obesity phenotypes and impaired MC3R function is less well established than that observed for loss of function mutations in the homologous MC4R.
Aim: Recently three heterozygous MC3R variants identified from candidate gene sequencing of an obese human cohort were reported to be pathogenic. We sought to functionally characterise the these MC3R non-synonymous variants (p.Q11X, p.I50T and p.A149V) in vitro and examine their associations to body mass index in an unselected population-based cohort.
Methodology: Functional characterisation of each variant was undertaken in HEK293 cells transiently overexpressing either wild-type MC3R or the respective MC3R mutant where cAMP-dependant luciferase activity in response to alpha-melanocyte stimulating hormone (α-MSH) was measured. Body mass index (BMI) was compared between heterozygous carriers of the MC3R variants of interest and control participants (matched for age and sex and ethnicity) identified within the UK Biobank whole exome sequencing dataset.
Results: Impairment of the canonical MC3R cAMP signalling response to α-MSH was observed for both p.Q11X and p.A149V MC3R variants when compared to wild-type MC3R receptor function in vitro. In contrast the cAMP signalling response of MC3R p.I50T to α-MSH was non-inferior to wild-type. Thirty-nine (male=18) heterozygous carriers of MC3R p.I50T were identified in the UK Biobank whole exome cohort. There was no statistical difference in median (IQR) BMI for female carriers 27.1(7.8) kg/m2 vs. matched female control participants 26.2(5.5) kg/m2 or male carriers 27.7(5.4) kg/m2 vs. matched male control participants 27.4(4.9) kg/m2. A single participant heterozygous for the MC3R p.Q11X variant (BMI= 28.3 kg/m2) and two participants heterozygous for MC3R p.A149V (BMI= 24.7 and 25.1 kg/m2 respectively) variant were identified in the UK Biobank whole exome cohort. BMI did not significantly differ from the match control population median for either of these variants.
Conclusion: In vitro assessment and phenotype correlates suggest that MC3R p.I50T is not an obesity causing mutation. Despite evidence of impaired receptor function in vitro, MC3R p.Q11X and p.A149V did not associate with obesity in this unselected population and further study are required to elucidate their pathogenicity in humans.
Collapse
Affiliation(s)
- Audrey Melvin
- Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom
| | - Ceili Cowan
- Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom
| | - Brian Lam
- Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom
| | - Sophie Buller
- Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom
| | - Kara Rainbow
- Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom
| | - Giles S Yeo
- Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom
| | - Stephen O’Rahilly
- Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom
| |
Collapse
|
3
|
Shaikh LH, Zhou J, Teo AED, Garg S, Neogi SG, Figg N, Yeo GS, Yu H, Maguire JJ, Zhao W, Bennett MR, Azizan EAB, Davenport AP, McKenzie G, Brown MJ. LGR5 Activates Noncanonical Wnt Signaling and Inhibits Aldosterone Production in the Human Adrenal. J Clin Endocrinol Metab 2015; 100:E836-44. [PMID: 25915569 PMCID: PMC4454794 DOI: 10.1210/jc.2015-1734] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/20/2015] [Accepted: 04/15/2015] [Indexed: 11/29/2022]
Abstract
CONTEXT Aldosterone synthesis and cellularity in the human adrenal zona glomerulosa (ZG) is sparse and patchy, presumably due to salt excess. The frequency of somatic mutations causing aldosterone-producing adenomas (APAs) may be a consequence of protection from cell loss by constitutive aldosterone production. OBJECTIVE The objective of the study was to delineate a process in human ZG, which may regulate both aldosterone production and cell turnover. DESIGN This study included a comparison of 20 pairs of ZG and zona fasciculata transcriptomes from adrenals adjacent to an APA (n = 13) or a pheochromocytoma (n = 7). INTERVENTIONS Interventions included an overexpression of the top ZG gene (LGR5) or stimulation by its ligand (R-spondin-3). MAIN OUTCOME MEASURES A transcriptome profile of ZG and zona fasciculata and aldosterone production, cell kinetic measurements, and Wnt signaling activity of LGR5 transfected or R-spondin-3-stimulated cells were measured. RESULTS LGR5 was the top gene up-regulated in ZG (25-fold). The gene for its cognate ligand R-spondin-3, RSPO3, was 5-fold up-regulated. In total, 18 genes associated with the Wnt pathway were greater than 2-fold up-regulated. ZG selectivity of LGR5, and its absence in most APAs, were confirmed by quantitative PCR and immunohistochemistry. Both R-spondin-3 stimulation and LGR5 transfection of human adrenal cells suppressed aldosterone production. There was reduced proliferation and increased apoptosis of transfected cells, and the noncanonical activator protein-1/Jun pathway was stimulated more than the canonical Wnt pathway (3-fold vs 1.3-fold). ZG of adrenal sections stained positive for apoptosis markers. CONCLUSION LGR5 is the most selectively expressed gene in human ZG and reduces aldosterone production and cell number. Such conditions may favor cells whose somatic mutation reverses aldosterone inhibition and cell loss.
Collapse
Affiliation(s)
- Lalarukh Haris Shaikh
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Junhua Zhou
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Ada E D Teo
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Sumedha Garg
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Sudeshna Guha Neogi
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Nichola Figg
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Giles S Yeo
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Haixiang Yu
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Janet J Maguire
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Wanfeng Zhao
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Martin R Bennett
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Elena A B Azizan
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Anthony P Davenport
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Grahame McKenzie
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| | - Morris J Brown
- Clinical Pharmacology Unit (L.H.S., J.Z., A.E.D.T., S.G., J.J.M., E.A.B.A., A.P.D., M.J.B.) and Cardiovascular Division (N.F., H.Y., M.R.B.), Department of Medicine, University of Cambridge, Cambridge National Institute for Health Research (S.G.N.), Biomedical Research Centre, Department of Clinical Biochemistry, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories (G.S.Y.), Institute of Metabolic Science, Addenbrooke's Hospital, and Human Research Tissue Bank (W.Z.), Cambridge University Hospitals Foundation Trust, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Medicine (E.A.B.A.), Faculty of Medicine, The National University of Malaysia Medical Centre, Kuala Lumpur 56000, Malaysia; and Medical Research Council Cancer Unit (G.M.), University of Cambridge, Cambridge CB2 0XZ, United Kingdom
| |
Collapse
|
4
|
Heng YHE, Zhou B, Harris L, Harvey T, Smith A, Horne E, Martynoga B, Andersen J, Achimastou A, Cato K, Richards LJ, Gronostajski RM, Yeo GS, Guillemot F, Bailey TL, Piper M. NFIX Regulates Proliferation and Migration Within the Murine SVZ Neurogenic Niche. Cereb Cortex 2014; 25:3758-78. [PMID: 25331604 DOI: 10.1093/cercor/bhu253] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Transcription factors of the nuclear factor one (NFI) family play a pivotal role in the development of the nervous system. One member, NFIX, regulates the development of the neocortex, hippocampus, and cerebellum. Postnatal Nfix(-/-) mice also display abnormalities within the subventricular zone (SVZ) lining the lateral ventricles, a region of the brain comprising a neurogenic niche that provides ongoing neurogenesis throughout life. Specifically, Nfix(-/-) mice exhibit more PAX6-expressing progenitor cells within the SVZ. However, the mechanism underlying the development of this phenotype remains undefined. Here, we reveal that NFIX contributes to multiple facets of SVZ development. Postnatal Nfix(-/-) mice exhibit increased levels of proliferation within the SVZ, both in vivo and in vitro as assessed by a neurosphere assay. Furthermore, we show that the migration of SVZ-derived neuroblasts to the olfactory bulb is impaired, and that the olfactory bulbs of postnatal Nfix(-/-) mice are smaller. We also demonstrate that gliogenesis within the rostral migratory stream is delayed in the absence of Nfix, and reveal that Gdnf (glial-derived neurotrophic factor), a known attractant for SVZ-derived neuroblasts, is a target for transcriptional activation by NFIX. Collectively, these findings suggest that NFIX regulates both proliferation and migration during the development of the SVZ neurogenic niche.
Collapse
Affiliation(s)
| | - Bo Zhou
- Department of Biochemistry, Programs in Neuroscience and Genetics, Genomics & Bioinformatics, Developmental Genomics Group, New York State Center of Excellence in Bioinformatics and Life Sciences, State University of New York at Buffalo, Buffalo, NY 14203, USA
| | | | | | | | | | - Ben Martynoga
- Division of Molecular Neurobiology, MRC-National Institute for Medical Research, London NW7 1AA, UK
| | - Jimena Andersen
- Division of Molecular Neurobiology, MRC-National Institute for Medical Research, London NW7 1AA, UK
| | - Angeliki Achimastou
- Division of Molecular Neurobiology, MRC-National Institute for Medical Research, London NW7 1AA, UK
| | | | | | - Richard M Gronostajski
- Department of Biochemistry, Programs in Neuroscience and Genetics, Genomics & Bioinformatics, Developmental Genomics Group, New York State Center of Excellence in Bioinformatics and Life Sciences, State University of New York at Buffalo, Buffalo, NY 14203, USA
| | - Giles S Yeo
- MRC Metabolic Diseases Unit, University of Cambridge Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK
| | - François Guillemot
- Division of Molecular Neurobiology, MRC-National Institute for Medical Research, London NW7 1AA, UK
| | - Timothy L Bailey
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia
| | - Michael Piper
- The School of Biomedical Sciences Queensland Brain Institute
| |
Collapse
|
5
|
Zuzarte R, Tan JV, Wee HY, Yeo GS. Prenatal diagnosis of trisomy 9. Singapore Med J 2011; 52:e150-e152. [PMID: 21808948] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
We present a foetus affected by trisomy 9, a rare chromosomal disorder, which was diagnosed in a low-risk patient during the first trimester of pregnancy. The finding of multiple structural foetal anomalies at the first trimester screening prompted chorionic villus sampling. Evaluation of the quantitative fluorescent polymerase chain reaction was normal, but the final karyotype result revealed a diagnosis of trisomy 9. First trimester screening for detection of foetal anomalies is highly effective. Although rapid molecular methods are available for prenatal diagnosis of common autosomal and sex chromosome aneuploidies, it is essential to obtain a full karyotype in order to exclude the less commonly encountered chromosomal abnormalities.
Collapse
Affiliation(s)
- R Zuzarte
- Department of Obstetrics and Gynaecology, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore 229899.
| | | | | | | |
Collapse
|
6
|
Mohd J, Tan J, Yeo GS. Management of foetal hydrops secondary to Kell isoimmunisation via foetal blood transfusion: a Doppler-guided approach. Singapore Med J 2009; 50:e143-e146. [PMID: 19421670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
We describe a male neonate with foetal hydrops due to foetal anaemia caused by Kell isoimmunisation. The severity of anaemia was monitored by Doppler ultrasonography of the middle cerebral artery peak systolic velocity, and this was used to time the foetal blood transfusions. The 33-year-old Indian mother received a total of five foetal blood transfusions from 21 weeks to 31 weeks of gestation, resulting in resolution of the anaemia and hydrops.
Collapse
Affiliation(s)
- J Mohd
- Department of Maternal Foetal Medicine, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore.
| | | | | |
Collapse
|
7
|
Tan KB, Tan KH, Chew SK, Yeo GS. Gastroschisis and omphalocele in Singapore: a ten-year series from 1993 to 2002. Singapore Med J 2008; 49:31-36. [PMID: 18204766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
INTRODUCTION Two of the most common malformations of the anterior abdominal wall include gastroschisis and omphalocele, both of which are associated with high morbidity and mortality. Studies have shown an increase in both conditions worldwide. These two conditions are considered separate entities because of their differences in epidemiology, physical characteristics and associations with other structural anomalies and chromosomal aberrations. This is the first local study to examine these two conditions. METHODS Data of anterior abdominal wall defect cases of patients born during the period 1993-2002 were retrieved from the National Birth Defects Registry and analysed. RESULTS There were a total of 121 cases of anterior abdominal wall defects in the ten-year period from 1993 to 2002, giving an overall incidence of 2.63 per 10,000 livebirths. The individual incidences of gastroschisis (n = 21) and omphalocele (n = 100) were 0.46 and 2.17 per 10,000 livebirths, respectively. 33 percent of women with foetal gastroschisis were younger than 25 years of age, and 31 percent of women with foetal omphalocele were older than 35 years of age. This was statistically significant when compared to the general obstetric population. Incidence of omphalocele was lowest among the Indian population. Total aneuploidy rate was 14.9 percent (18/121 cases), with omphalocele having a higher aneuploidy rate than gastroschisis (17 percent versus 4.8 percent). Omphaloceles are also more likely to be associated with cardiac defects (p-value equals 0.02). CONCLUSION Our studies are consistent with the worldwide trend of an increasing prevalence of anterior abdominal wall defects. The race-specific differences suggest genetic and environmental factors that warrant further studies.
Collapse
Affiliation(s)
- K B Tan
- National Birth Defects Registry, Ministry of Health, c/o KK Women's and Children's Hospital, Level 7, Children's Tower, 100 Bukit Timah Road, Singapore 229899
| | | | | | | |
Collapse
|
8
|
Sia AT, Kwek K, Yeo GS. The in vitro effects of clonidine and dexmedetomidine on human myometrium. Int J Obstet Anesth 2005; 14:104-7. [PMID: 15795144 DOI: 10.1016/j.ijoa.2004.11.004] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/01/2004] [Revised: 11/01/2004] [Accepted: 11/01/2004] [Indexed: 11/29/2022]
Abstract
BACKGROUND alpha(2)-adrenergic agonists have been used extensively in the field of anaesthesia. Their direct effect on the human myometrium was investigated in this in vitro study, as this may have clinical repercussions in obstetric anaesthesia. METHOD Strips of pregnant human myometrium obtained from six individuals at elective caesarean section were mounted on the Mulvany myograph in Krebs solution to which increasing concentrations of clonidine and dexmedetomidine (1x10(-11) to 1x10(-6) g/mL) were added. RESULTS Dexmedetomidine increased uterine contractility at simulated clinical plasma concentrations (1x10(-9) g/mL). These effects were seen with clonidine only at much higher tissue bath concentrations (1x10(-7) g/mL). CONCLUSION The effect of dexmedetomidine on human myometrium has profound implications in obstetric anaesthesia and needs further clinical investigation.
Collapse
Affiliation(s)
- A T Sia
- Department of Anaesthesia, Division of Obstetrics and Gynaecology, KK Women's and Children's Hospital, Singapore.
| | | | | |
Collapse
|
9
|
Kwek K, Khi C, Ting HS, Yeo GS. Evaluation of a bedside test for phosphorylated insulin-like growth factor binding protein-1 in preterm labour. Ann Acad Med Singap 2004; 33:780-3. [PMID: 15608838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
OBJECTIVE The objective of this study was to assess the efficacy of a bedside test kit for phosphorylated insulin-like growth factor binding protein-1 (IGFBP-1) in the diagnosis of preterm labour and the prediction of subsequent preterm delivery. MATERIALS AND METHODS We performed a bedside test for IGFBP-1 in 47 women who presented to the delivery suite in suspected preterm labour between 23 and 33 weeks. Tocolysis and steroid therapy were administered in all cases. RESULTS Twenty-nine women (61.7%) tested negative and 18 women tested positive (38.3%). There was no statistical significance between the 2 groups except that the test-positive group had a greater median cervical dilatation (2.0 cm) compared to the testnegative group (1.0 cm) (P <0.05). The women who tested positive had a statistically significant longer median duration of hospitalisation, stay in delivery suite and tocolytic therapy (5.0 days, 56.0 hours and 34.5 hours respectively) compared to women who were test-negative (3.0 days, 19.0 hours and 10.0 hours respectively) (P <0.05). In addition, 91.7% of the patients in the IGFBP-1 negative group had a delay of more than 7 days between the onset of contractions and delivery, while only 44.4% of the women in the pIGFBP-1 positive group experienced such a delay. CONCLUSION These results suggest that there may be a role for cervical IGFBP-1 test in the management of women presenting with suspected preterm labour. It may allow us to focus our efforts on women who are more likely to have a preterm delivery and perhaps allow us to avoid unnecessary treatment and to contain healthcare costs.
Collapse
Affiliation(s)
- K Kwek
- Department of Maternal Fetal Medicine, KK Women's and Children's Hospital, Singapore.
| | | | | | | |
Collapse
|
10
|
Wong JP, Seow WT, Yeo GS. Characteristics of six newborn infants with postnatal findings of severe intracranial haemorrhage. Ann Acad Med Singap 2004; 33:789-92. [PMID: 15608840] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
OBJECTIVE The objective of this study was to study the characteristics of newborn infants with postnatal findings of severe neonatal intracranial haemorrhage. METHODS All the records of babies who underwent surgery from 1997 to 2002 for intracranial haemorrhage were reviewed. These were correlated with their antenatal records to see if fetal intracranial haemorrhage had been detected at the 20 weeks' screening scan or any other incidental scan e.g. growth scan. The perinatal records were also reviewed to see if there was associated birth trauma such as instrumentation or obstetric manoeuvres at delivery. RESULTS Six cases of severe intracranial haemorrhage were diagnosed postnatally. Of these, only 1 case was detected antenatally on ultrasound scan. None of the cases were due to birth trauma. Three babies were found to have clotting factor deficiency. One of them subsequently developed cerebral palsy. One baby was diagnosed to have alloimmune thrombocytopenia. One case underwent an emergency Caesarean section for non-reassuring fetal status. Extensive intracranial haemorrhage, attributed to hypoxia, was found. The baby died. CONCLUSIONS Our study suggests that neonatal intracranial haemorrhages are not exclusively due to birth trauma. The study also shows that fetal intracranial haemorrhage may not be detected antenatally by the routine practice. The causes in our study included clotting deficiency, alloimmune thrombocytopenia and hypoxia.
Collapse
Affiliation(s)
- J P Wong
- Department of General Obstetrics and Gynaecology, KK Women's and Children's Hospital, Singapore
| | | | | |
Collapse
|
11
|
Yeo GS. Inaugural College of Obstetricians & Gynaecologists Lecture: recent developments in obstetric care and maternal fetal medicine in Singapore. Ann Acad Med Singap 2004; 33:738-42. [PMID: 15608830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Affiliation(s)
- G S Yeo
- Department of Maternal Fetal Medicine, KK Women's and Children's Hospital, Singapore
| |
Collapse
|
12
|
Lau MS, Tan JV, Tan TY, Gomez JM, Yeo GS. Idiopathic chronic fetomaternal haemorrhage resulting in hydrops--a case report. Ann Acad Med Singap 2003; 32:642-4. [PMID: 14626793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
INTRODUCTION We report a case of idiopathic chronic fetomaternal haemorrhage (FMH) that developed in the late trimester. CLINICAL PRESENTATION The patient presented with decreased fetal movement at 38 weeks gestation. Antenatal follow-up was uneventful with normal serial ultrasound performed at 22 and 35 weeks. Prior to delivery, the cardiotocography (CTG) was abnormal with decreased baseline variability and late deceleration. Emergency lower segment caesarean section was performed. Upon delivery, a hydropic neonate with a haemoglobin level of 3.9 g/dL was noted. The Kleihauer-Betke test was positive, confirming FMH. OUTCOME The neonate later developed intraventricular haemorrhage (IVH) and spastic cerebral palsy on follow-up. DISCUSSION It is possible for FMH to occur late at the third trimester leading to detrimental effect. The fact that FMH can occur without antecedent risk factors underscores the importance of further research, and a high index of suspicion.
Collapse
Affiliation(s)
- M S Lau
- Department of Maternal Fetal Medicine, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore 229899.
| | | | | | | | | |
Collapse
|
13
|
Tan TC, Tan TY, Kwek KY, Tee JC, Rajadurai VS, Yeo GS. Severe newborn encephalopathy unrelated to intrapartum hypoxic events: 3 case reports. Ann Acad Med Singap 2003; 32:653-7. [PMID: 14626796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
INTRODUCTION Newborn encephalopathy is an important clinical problem associated with considerable morbidity and mortality and is pertinent in the assignment of blame in obstetrics litigation. CLINICAL PICTURE We report 3 babies with severe neonatal encephalopathy. OUTCOME In all 3 cases, intrapartum hypoxic insult was unlikely to be a significant contributing factor towards the development of neonatal encephalopathy. The aetiology was unclear in the first 2 cases and there was antecedent antenatal cause of feto-maternal haemorrhage in the last case. CONCLUSION Prevention of neonatal encephalopathy was not possible in these 3 cases. We recommend that umbilical cord blood gases be clearly documented in such cases to reduce unnecessary obstetrics litigation of intrapartum asphyxia as the significant contributing factor to the poor neonatal outcome. Clinicians must have a high index of suspicion of antecedent causes and perform the necessary investigations to elucidate the aetiology of the neonatal encephalopathy.
Collapse
Affiliation(s)
- T C Tan
- Department of Maternal Fetal Medicine, KK Women's & Children's Hospital, 100 Bukit Timah Road, Singapore 229899
| | | | | | | | | | | |
Collapse
|
14
|
Wee HY, Tan TY, Khoo PC, Agarwal P, Yeo GS. A case series of pre-viable severe twin-twin transfusion syndrome. Ann Acad Med Singap 2003; 32:645-8. [PMID: 14626794] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
INTRODUCTION We present a case series of pre-viable severe twin-twin transfusion syndrome (TTTS). CLINICAL PICTURE In year 2000, there were 16,688 deliveries in KK Women's and Children's Hospital. Four cases that presented before 24 weeks gestation satisfied the sonographic criteria for severe TTTS: same-sex fetuses, absence of twin peak sign, thin intertwine membrane, polyhydramnios associated with large bladder in recipient twin, and oligohydramnios and small or absent bladder in donor twin. TREATMENT Amnioreduction, septostomy and termination of pregnancy were offered. OUTCOME In 1 case abortion was chosen. The follow-up was at least 18 months postnatal. There was 1 intrauterine death, 2 with severe neurological handicap and 3 with normal outcome. CONCLUSION Pre-viable severe TTTS is associated with significant mortality and morbidity rates and should be diagnosed promptly and managed in a tertiary fetal medicine unit with multi-disciplinary input.
Collapse
Affiliation(s)
- H Y Wee
- Department of Maternal Fetal Medicine, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore 229899.
| | | | | | | | | |
Collapse
|
15
|
Tan HH, Tan VC, Yeo GS. A case series of gastrointestinal abnormalities in fetuses with echogenic bowel detected during the antenatal period. Ann Acad Med Singap 2003; 32:649-52. [PMID: 14626795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
OBJECTIVE The objective was to evaluate the incidence of gastrointestinal abnormalities amongst those fetuses with antenatally diagnosed echogenic bowel (EB). MATERIALS AND METHODS A retrospective review of all cases delivered from April 2002 to March 2003 with antenatally diagnosed EB was conducted. This was defined as bowel that appeared as echogenic as (if not greater than) the iliac bone on a real-time image. The postnatal outcomes with regard to gastrointestinal abnormalities, till their discharge, were noted. RESULTS Of the 13,941 patients delivered, there were 70 cases with antenatally diagnosed EB, giving an incidence of 70/13,941 or 0.50%. Of these, 6 defaulted follow-up and 1 had a mid-trimester termination of pregnancy at 21 weeks' gestation for social reasons. Of the remaining 63 cases with EB, 2 were stillbirths at 31 weeks and 35 weeks of gestation, respectively. Three fetuses (3/63 or 4.76%) were diagnosed with gastrointestinal abnormalities. Meconium plug syndrome was diagnosed postnatally in 2 cases, of which, 1 resolved with conservative management while the other required an emergency laparotomy. Intestinal atresia was diagnosed in the postmortem of one of the stillbirths. There was evidence of intrauterine growth retardation (IUGR) in both the stillbirth and the fetus that had required laparotomy. None of the 3 fetuses exhibited clinical features of aneuploidy. CONCLUSION As the quoted background risk for gastrointestinal pathology is 0.23%, an increased incidence (4.76%) is observed in those fetuses found to have antenatal EB. It is possible that the presence of IUGR is associated with a worse prognosis. Further prospective studies are needed to verify this association.
Collapse
Affiliation(s)
- H H Tan
- Department of Maternal Fetal Medicine, KK Women's & Children's Hospital, 100 Bukit Timah Road, Singapore 229899
| | | | | |
Collapse
|
16
|
Farooqi IS, Yeo GS, O'Rahilly S. Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003; 349:606-9; author reply 606-9. [PMID: 12908459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Grants] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/04/2023]
|
17
|
Tan TY, Yeo GS. Advances in imaging in prenatal diagnosis and fetal therapy. Ann Acad Med Singap 2003; 32:289-93. [PMID: 12854370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/03/2023]
Abstract
Technological advances in ultrasound have contributed to improvements in prenatal diagnosis. Transvaginal scanning and harmonic imaging have allowed better resolution and improved structural characterisation. Doppler techniques have further been improved, which allow accurate flow studies of vessels in the placenta and fetus. These have contributed much to the management of intrauterine growth restriction, fetal anaemia and twin-twin transfusion syndrome (TTTS). Three-dimensional sonography and magnetic resonance imaging ultrafast sequences are useful adjuncts to conventional 2-dimensional sonography, increasing the confidence and diagnostic accuracy of prenatal diagnosis. Fetal therapy has seen major advances in recent years as well, secondary to improvements in endoscopic instruments and surgical techniques. Selective Nd:YAG laser photocoagulation of communicating vessels and cord occlusion have been used to treat complications of monochorionic twins like TTTS and twin-reversed arterial perfusion sequence.
Collapse
Affiliation(s)
- T Y Tan
- Department of Maternal Fetal Medicine, Division of Obstetrics, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore 229899.
| | | |
Collapse
|
18
|
Wong JP, Kwek KY, Tan JY, Yeo GS. Fetal congenital complete heart block: prophylaxis with intravenous gammaglobulin and treatment with dexamethasone. Aust N Z J Obstet Gynaecol 2001; 41:339-41. [PMID: 11592556 DOI: 10.1111/j.1479-828x.2001.tb01243.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
We report a case of complete fetal heart block in a 35-year-old Chinese woman known to be positive for anti-SSA/Ro and anti-SSB/La antibodies. She had fetal hydrops leading to intrauterine death in her first pregnancy Prophylactic intravenous immunoglobulin, given at 14 and 18 weeks' gestation, as well as oral dexamethasone, commenced at 24 weeks' gestation, allowed continuation of the pregnancy until 34 completed weeks of gestation. An external pacemaker was inserted in the baby on the first day of life. Two-and-a-half months later, a permanent pacemaker was inserted.
Collapse
Affiliation(s)
- J P Wong
- Department of General Obstetrics and Gynaecology, Kandang Kerbau Women's and Children's Hospital, Singapore
| | | | | | | |
Collapse
|
19
|
Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T, O'Rahilly S. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000; 106:271-9. [PMID: 10903343 PMCID: PMC314308 DOI: 10.1172/jci9397] [Citation(s) in RCA: 517] [Impact Index Per Article: 21.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Over 20 severely obese subjects in 11 independent kindreds have been reported to have pathogenic heterozygous mutations in the gene encoding the melanocortin 4 receptor (MC4R), making this the most common known monogenic cause of human obesity. To date, the detailed clinical phenotype of this dominantly inherited disorder has not been defined, and no homozygous subjects have been described. We determined the nucleotide sequence of the entire coding region of the MC4R gene in 243 subjects with severe, early-onset obesity. A novel two-base pair GT insertion in codon 279 was found in two unrelated subjects, and four novel missense mutations, N62S, R165Q, V253I, C271Y, and one mutation (T112M) reported previously were found in five subjects. N62S was found in homozygous form in five children with severe obesity from a consanguineous pedigree. All four heterozygous carriers were nonobese. Several features of the phenotype, e.g. hyperphagia, tendency toward tall stature, hyperinsulinemia, and preserved reproductive function, closely resemble those reported previously in Mc4r knock-out mice. In addition, a marked increase in bone mineral density was seen in all affected subjects. In transient transfection assays, the N62S mutant receptor showed a responsiveness to alphaMSH that was intermediate between the wild-type receptor and mutant receptors carrying nonsense and missense mutations associated with dominantly inherited obesity. Thus MC4R mutations result in a syndrome of hyperphagic obesity in humans that can present with either dominant or recessive patterns of inheritance.
Collapse
Affiliation(s)
- I S Farooqi
- University Departments of Medicine and Clinical Biochemistry, Addenbrooke's Hospital, Cambridge, United Kingdom
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Challis BG, Yeo GS, Farooqi IS, Luan J, Aminian S, Halsall DJ, Keogh JM, Wareham NJ, O'Rahilly S. The CART gene and human obesity: mutational analysis and population genetics. Diabetes 2000; 49:872-5. [PMID: 10905499 DOI: 10.2337/diabetes.49.5.872] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
The cocaine- and amphetamine-regulated transcript (CART) peptide is a recently characterized neuropeptide implicated in the control of appetite. We hypothesized that genetic variation in CART may contribute to human obesity. The entire coding region of CART was determined by nucleotide sequencing in 91 unrelated subjects with severe early-onset obesity. A novel amino acid change, Ser66Thr, was found in 2 probands and in 0 of 100 control subjects but did not cosegregate with obesity in family studies. Two common polymorphisms were found in the 3'-untranslated region (A1475G and deltaA1457). An effect of these polymorphisms on body composition and intermediate phenotypes related to obesity was examined in a large Caucasian population in the U.K. Neither polymorphism showed any significant relationship with obesity; however, men heterozygous for the A1475G variant had significantly lower waist-to-hip ratio (WHR), fasting plasma insulin, and fasting triglycerides. Regression analysis indicated that the effects on insulin and triglycerides were likely to be secondary to the effects on WHR. Thus, we have conducted the first systematic study of the CART gene in human obesity, and although no clear association with obesity was found, the data suggest that genetic variation in the CART locus might influence fat distribution and variables related to syndrome X.
Collapse
Affiliation(s)
- B G Challis
- University Department of Medicine, Addenbrooke's Hospital, Cambridge, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Wong A, Tan KH, Tee CS, Yeo GS. Seroprevalence of cytomegalovirus, toxoplasma and parvovirus in pregnancy. Singapore Med J 2000; 41:151-5. [PMID: 11063178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
AIM OF STUDY The aim of our study was to determine the seroprevalence of cytomegalovirus (CMV), toxoplasma and parvovirus infection in our local antenatal population, and to see the effects, if any, of age, race, parity and nationality on its seroprevalence. METHODOLOGY The sera of 120 consecutive antenatal women seen in KK Women's and Children's Hospital between the period of October 1997 and March 1998 were screened for cytomegalovirus (CMV) IgG, toxoplasma IgG and parvovirus B19 IgG and IgM. An antibody titer greater than 1:32 was regarded as positive. RESULTS A total of 87.0% of patients were tested seropositive for CMV IgG, 17.2% seropositive for toxoplasma IgG and 30.0% seropositive for parvovirus IgG. There seemed to be a trend of increasing seropositivity with age in all three groups, however only parovirus B19 reached statistical significance. The incidence of all three infections were higher among the Malays, Indians and other races compared to the Chinese. CONCLUSION CMV is endemic in our population and hence the most common infection. Toxoplasmosis and parvovirus is relatively low in our population but this implies that a large proportion of our antenatal women are still susceptible to these infections. Prevention of congenital CMV, toxoplasmosis and parvovirus infection is mainly by educating the antenatal population.
Collapse
Affiliation(s)
- A Wong
- Department of Maternal-Fetal Medicine, KK Women's and Children's Hospital, Singapore
| | | | | | | |
Collapse
|
22
|
Yeo GS, Farooqi IS, Challis BG, Jackson RS, O'Rahilly S. The role of melanocortin signalling in the control of body weight: evidence from human and murine genetic models. QJM 2000; 93:7-14. [PMID: 10623776 DOI: 10.1093/qjmed/93.1.7] [Citation(s) in RCA: 84] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The peptide products of the pro-opiomelanocortin (POMC) gene have established roles in the control of physiological processes as diverse as adrenal steroidogenesis, skin pigmentation, analgesia and inflammation. In the last 5 years, evidence accumulated from murine and human genetic models of disrupted melanocortin signalling has firmly established a central role for a population of hypothalamic neurons expressing POMC in the control of appetite and body weight. Of the five known melanocortin receptors, the MC4R has been most closely linked to body weight regulation. While a-MSH is active at this receptor and suppresses appetite after central injection, important roles for other POMC-derived products have not been excluded. The development of pharmacological agonists acting on, or mimicking, the hypothalamic melanocortinergic pathway may provide exciting opportunities for the therapy of human obesity.
Collapse
Affiliation(s)
- G S Yeo
- Departments of Medicine and Clinical Biochemistry, Cambridge Institute for Medical Research, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK
| | | | | | | | | |
Collapse
|
23
|
Elgar G, Clark MS, Meek S, Smith S, Warner S, Edwards YJ, Bouchireb N, Cottage A, Yeo GS, Umrania Y, Williams G, Brenner S. Generation and analysis of 25 Mb of genomic DNA from the pufferfish Fugu rubripes by sequence scanning. Genome Res 1999; 9:960-71. [PMID: 10523524 PMCID: PMC310822 DOI: 10.1101/gr.9.10.960] [Citation(s) in RCA: 68] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
We have generated and analyzed >50,000 shotgun clones from 1059 Fugu cosmid clones. All sequences have been minimally edited and searched against protein and DNA databases. These data are all displayed on a searchable, publicly available web site at. With an average of 50 reads per cosmid, this is virtually nonredundant sequence skimming, covering 30%-50% of each clone. This essentially random data set covers nearly 25 Mb (>6%) of the Fugu genome and forms the basis of a series of whole genome analyses which address questions regarding gene density and distribution in the Fugu genome and the similarity between Fugu and mammalian genes. The Fugu genome, with eight times less DNA but a similar gene repertoire, is ideally suited to this type of study because most cosmids contain more than one identifiable gene. General features of the genome are also discussed. We have made some estimation of the syntenic relationship between mammals and Fugu and looked at the efficacy of ORF prediction from short, unedited Fugu genomic sequences. Comparative DNA sequence analyses are an essential tool in the functional interpretation of complex vertebrate genomes. This project highlights the utility of using the Fugu genome in this kind of study.
Collapse
Affiliation(s)
- G Elgar
- UK Human Genome Mapping Project (HGMP) Resource Centre, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SB, UK.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
This study was a retrospective analysis of the pattern of usage of both the forceps and vacuum extractor as well as the neonatal outcome on all the instrumental deliveries conducted in 1995 at the Kandang Kerbau Hospital, Singapore. There were a total of 927 forceps deliveries and 495 vacuum extractions but neonatal data was available for only 481 forceps and 255 vacuum extractor babies. (There were 2 neonatal units which accepted admissions on alternate days; all of the data were collected from 1 of the units only). Demographic data were comparable in most aspects except that vacuum deliveries were significantly associated with higher parity and shorter labours. There was a trend towards using the vacuum extractor in less difficult cases. Almost all the instrumental deliveries were conducted by specialists. Birth trauma was significantly more likely to occur with the vacuum extractor. Almost all the deliveries were conducted with similar expertise in both groups, yet the use of the vacuum extractor resulted in more birth trauma even in the presence of 'easier' cases. This may suggest an inherent risk in using the vacuum extractor.
Collapse
Affiliation(s)
- C C Chan
- Department of Maternal Fetal Medicine, Kandang Kerbau Women's and Children's Hospital, Singapore
| | | | | |
Collapse
|
25
|
Abstract
OBJECTIVE Confidential panel enquiry into sub-optimal factors relating to stillbirths. METHOD All 121 stillbirths in KK Women's and Children's Hospital in the years 1995 and 1996 were studied. Three assessors reviewed the case records of each death, and panel consensus was reached regarding sub-optimal antenatal care and factors leading to stillbirths. RESULT The incidence rate of stillbirth was 4.04 per 1000 deliveries. A total of 76 cases (62.8%) were found to have grade II and III sub-optimal factors in their management. Patients themselves were involved in the sub-optimal management of their own pregnancy in 52.9% of the stillbirths. Primary healthcare givers were involved in 8.3% of all stillbirths, specialist caregivers 12.4% and antenatal care system 4.1%. CONCLUSION The study has identified sub-optimal antenatal management in over 60% of cases. As patients' factors form the major contribution towards sub-optimal care, management strategy aimed towards improving patients' education and compliance to antenatal care should be a priority.
Collapse
Affiliation(s)
- W L Tham
- Department of Maternal Fetal Medicine, KK Women's and Children's Hospital, Singapore, Singapore
| | | | | | | |
Collapse
|
26
|
Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998; 20:111-2. [PMID: 9771698 DOI: 10.1038/2404] [Citation(s) in RCA: 716] [Impact Index Per Article: 27.5] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
27
|
Abstract
Use of an automated electronic sphygmomanometer will allow us to minimize the errors inherent in mercury sphygmomanometry. We conducted this validation according to the 1990 protocol of the British Hypertensive Society. We recruited 87 subjects from the antenatal population of Kandang Kerbau Hospital and took three sequential readings using simultaneously both manual and electronic sphygmomanometry. A total of 261 readings from either method were thus collected and the results analyzed to compare the accuracy of electronically read blood pressure with that assessed manually. We found that 89.9% of the electronically read pressures differed from the manually read pressures by 5 mm Hg or less and 98.9% of the electronic readings differed from manual readings by 10 mm Hg or less; only 0.4% of readings had a difference of more than 15 mm Hg. The accuracy of the device was not affected either by the blood pressure or the arm circumference.
Collapse
Affiliation(s)
- K Kwek
- Department of Maternal Fetal Medicine, Kandang Kerbau Women's and Children's Hospital, Singapore, Republic of Singapore. kenjinpacific.net.sg
| | | | | | | |
Collapse
|
28
|
Kim SH, Yeo GS, Lim YS, Kang CD, Kim CM, Chung BS. Suppression of multidrug resistance via inhibition of heat shock factor by quercetin in MDR cells. Exp Mol Med 1998; 30:87-92. [PMID: 9873828 DOI: 10.1038/emm.1998.13] [Citation(s) in RCA: 49] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
MDR1 promoter has been shown to contain heat shock elements (HSE), and it has been reported that FM3A/M and P388/M MDR cells show a constitutively activated heat shock factor (HSF), suggesting that HSF might be an important target for reversing the multidrug resistance. Therefore, it was examined whether quercetin, which has been shown to interfere with the formation of the complex between HSE and HSF, and to downregulate the level of HSF1, can sensitize MDR cells against anticancer drugs by inhibition of HSF DNA-binding activity. In this study, quercetin appeared to inhibit the constitutive HSF DNA-binding activity and the sodium arsenite-induced HSF DNA-binding activity in the MDR cells. The basal and sodium arsenite-induced MDRCAT activities were remarkably suppressed by the treatment of quercetin. These results were well consistent with the finding that the treatment of quercetin decreased the expression level of P-gp, MDR1 gene product, in dose-dependent manner, and markedly increased the sensitivity of MDR cells to vincristine or vinblastine. These results suggest that quercetin can decrease the expression of P-gp via inhibition of HSF DNA-binding activity, and might be useful as a chemosensitizer in MDR cells.
Collapse
Affiliation(s)
- S H Kim
- Department of Biochemistry, College of Medicine, Pusan National University, Korea
| | | | | | | | | | | |
Collapse
|
29
|
Loh SF, Woodworth A, Yeo GS. Umbilical cord blood gas analysis at delivery. Singapore Med J 1998; 39:151-5. [PMID: 9676144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
BACKGROUND Umbilical cord blood gas values are better indicators of perinatal asphyxia than Apgar scores. However, the reported normal range of umbilical blood gas values vary greatly in the literature. The aim of this prospective study was to establish the normal range of umbilical cord blood gas values in our labour ward. METHODS AND RESULTS Umbilical cord blood gas from 153 vaginal deliveries and 52 Caesarean sections for indication other than fetal distress were evaluated. In our labour ward, the mean and standard deviation of umbilical artery pH were 7.21 and 0.08 for vaginal deliveries and 7.22 and 0.07 for Caesarean sections respectively. The mean and standard deviation for umbilical artery base deficit were 5.08 and 3.85 for vaginal deliveries and 4.09 and 3.07 for Caesarean sections respectively. CONCLUSION In conclusion, pH of 7.05 is the statistical lower limit of umbilical artery pH in our labour ward and is a good cut-off value to indicate perinatal asphyxia. Five cases with abnormal umbilical artery pH (< 7.05) were also analysed and discussed.
Collapse
Affiliation(s)
- S F Loh
- Department of Maternal-Fetal Medicine, KK Women's and Children's Hospital, Singapore
| | | | | |
Collapse
|
30
|
Lai FM, Yeo GS. Down syndrome screening in Singapore--the effectiveness of a second trimester serum screening policy modelled on 29,360 pregnancies in KK Women's and Children's Hospital. Singapore Med J 1998; 39:69-75. [PMID: 9652180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
AIM OF STUDY To assess the effectiveness of a proposed second trimester Down syndrome serum screening policy in Singapore. METHOD Auditing the effectiveness of an age-only policy and comparing it against a serum screening policy modelled on the same maternal population of KK Women's and Children's Hospital in 1994 and 1995. RESULTS KK Women's and Children's Hospital's (KKH) maternal age distribution is similar to the national age distribution of mothers. Sixteen percent (16.7%) of mothers in KKH, in 1994 and 1995, were 35 years or older at delivery. Based on our hospital birth defect registry, 66% (35/53) of Down Syndrome pregnancies occurred in mothers who were 35 years or older at delivery and 43% (23/53) in the oldest 6.5% of mothers (38 years or older at delivery). Using various models on KKH's population structure to estimate the expected number of Down Syndrome livebirths expected, 52%-55% and 34%-36% of Down Syndrome livebirths were expected to occur in the oldest 16.7% and 6.5% of mothers respectively. These simulated figures are much lower than the figures from the data and needs further study, assuming that the Western Down Syndrome risk model to be applicable to our population. The overall uptake of amniocentesis irrespective of gestational age at booking was 28%. In mothers who were 35 years or older at delivery and booked before 22 weeks gestation, the uptake rate of amniocentesis was 49%. There was a substantial difference in the uptake rate when the counselling was done by trained counsellers compared to those who were not. CONCLUSION We would expect that for a fixed amniocentesis rate of 6.5% and 16.7%, serum screening would be able to detect 71% and 85% respectively of the Down syndrome pregnancies. This is more efficient than figures published from Western populations as our patients are older.
Collapse
Affiliation(s)
- F M Lai
- Department of Maternal-Fetal Medicine, KK Women's and Children's Hospital, Singapore
| | | |
Collapse
|
31
|
Chang TC, Chew TS, Pang M, Tan AC, Yeo GS. Cervicovaginal foetal fibronectin in the prediction of preterm labour in a low-risk population. Ann Acad Med Singap 1997; 26:776-80. [PMID: 9522979] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The aim of this study was to evaluate the role of cervicovaginal fibronectin as a screening test in a low-risk population. Swabs were taken from the posterior fornix at 28 weeks gestation and foetal fibronectin levels were assayed using enzyme immunoassay. Eighteen patients (7.7%) delivered at less than 37 weeks of gestation, and 6 (2.4%) at less than 34 weeks of gestation. Five patients (2.1%) had a positive fibronectin test result. The sensitivity, specificity, positive predictive value and negative predictive value in the prediction of delivery less than 37 weeks of gestation were 16.7%, 99.1%, 60.0% and 93.4%, respectively. The sensitivity of foetal fibronectin in the prediction of delivery less than 34 weeks of gestation was higher (50%) compared with the prediction of delivery less than 37 weeks of gestation (16.7%). The low sensitivity of this test suggests a limited role for cervicovaginal fibronectin in the low-risk population. Further studies need to be carried out to assess whether multiple testing of cervicovaginal fibronectin at different gestational ages will further increase the sensitivity.
Collapse
Affiliation(s)
- T C Chang
- Department of Maternal Fetal Medicine, Singapore General Hospital, Singapore
| | | | | | | | | |
Collapse
|
32
|
Chang TC, Tan KT, Neow P, Yeo GS. Computerised analysis of foetal heart rate variation: prediction of adverse perinatal outcome in patients undergoing prostaglandin induction of labour at term. Ann Acad Med Singap 1997; 26:772-5. [PMID: 9522978] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The aim of this study was to determine the value of antenatal numerical assessment of foetal heart rate variation in the prediction of adverse perinatal outcome in patients undergoing prostaglandin induction of labour at term. Two hundred and seven patients who underwent prostaglandin cervical ripening after 37 weeks gestation for the indications of pregnancy-induced hypertension, foetal growth retardation or post-dates pregnancy were included in this study. Prior to commencement of cervical ripening, a 30-minute cardiotocography tracing was recorded on the System 8000 machine and the long-term and short-term variations were calculated. Forty-three patients (20.8%) had a long-term variation of less than 30 ms; 9 (4.3%) had a short-term variation of less than 3 ms. The sensitivity and positive predictive values of long-term variation in the prediction of admission to neonatal special care unit were 25.6% and 23.2%, respectively. Corresponding values for short-term variation were 2.6% and 11.1%, respectively. The sensitivity and positive predictive values of long-term variation in the prediction of caesarean section for foetal distress were 33.3% and 9.3%, respectively. Corresponding values for short-term variation were 8.3% and 11.1%, respectively. Long-term and short-term variations appeared to be both poor predictors of adverse perinatal outcome. However, of 4 foetuses with both reduced antenatal heart rate variation and who were subsequently delivered by caesarean section for foetal distress in labour, all 4 were admitted to neonatal special care unit (NSCU). Foetuses with intrapartum evidence of foetal distress were more likely to be admitted to NSCU when antenatal foetal heart rate variation was reduced.
Collapse
Affiliation(s)
- T C Chang
- Department of Maternal Fetal Medicine, Kandang Kerbau Hospital, Singapore
| | | | | | | |
Collapse
|
33
|
Abstract
The Japanese pufferfish Fugu rubripes has a 400 Mb genome with high gene density and minimal non-coding complexity, and is therefore an ideal vertebrate model for sequence comparison. The identification of regions of conserved synteny between Fugu and humans would greatly accelerate the mapping and ordering of genes. Fugu C9 was cloned and sequenced as a first step in an attempt to characterize the region in Fugu homologous to human chromosome 5p13. The 11 exons of the Fugu C9 gene share 33% identity with human C9 and span 2.9 kb of genomic DNA. By comparison, human C9 spans 90 kb, representing a 30-fold difference in size. We have also determined by cosmid sequence scanning that DOC-2, a tumour suppresser gene which also maps to human 5p13, lies 6-7 kb from C9 in a head-to-head or 5' to 5' orientation. These results demonstrate that the Fugu C9/DOC-2 locus is a region of conserved synteny. Sequence scanning of overlapping cosmids has identified two other genes, GAS-1 and FBP, both of which map to human chromosome 9q22, and lie adjacent to the Fugu C9/DOC-2 locus, indicating the boundary between two syntenic regions.
Collapse
MESH Headings
- Adaptor Proteins, Signal Transducing
- Adaptor Proteins, Vesicular Transport
- Amino Acid Sequence
- Animals
- Apoptosis Regulatory Proteins
- Base Sequence
- Chromosome Mapping
- Chromosomes, Human, Pair 5
- Chromosomes, Human, Pair 9
- Cloning, Molecular
- Complement C9/biosynthesis
- Complement C9/chemistry
- Complement C9/genetics
- Conserved Sequence
- Cosmids
- Exons
- Fishes/genetics
- Genes, Tumor Suppressor
- Genetic Linkage
- Humans
- Introns
- Molecular Sequence Data
- Protein Biosynthesis
- Proteins/chemistry
- Proteins/genetics
- Recombinant Proteins/biosynthesis
- Recombinant Proteins/chemistry
- Sequence Alignment
- Sequence Homology, Amino Acid
- Sequence Homology, Nucleic Acid
- Tumor Suppressor Proteins
Collapse
Affiliation(s)
- G S Yeo
- Molecular Genetics, University of Cambridge Department of Medicine, Addenbrookes Hospital, UK.
| | | | | | | |
Collapse
|
34
|
Koh GH, Yeo GS. Diagnosis of ectopic pregnancy--why we need a protocol. Singapore Med J 1997; 38:369-74. [PMID: 9407760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
OBJECTIVE To audit the management after instituting a screening programme for ectopic pregnancy in an institution with a protocol utilising ultrasound examination and serial human chorionic gonadotropin (hCG) and to examine the risk of missed diagnosis with deviation from the protocol. MATERIAL AND METHOD A retrospective analysis of the management of 145 symptomatic patients in early pregnancies without intrauterine gestational sacs from ultrasound examinations, during the period April to June 1994 in Kandang Kerbau Hospital. Patients underwent serial hCG tests over 48 hours with or without repeat ultrasound scans before definitive treatment unless clinical indications for emergency surgery was necessary. RESULTS There were 35 ectopic pregnancies (24%), 16 were viable intrauterine pregnancies (11%), 87 were non-viable pregnancies (60%) and 7 were of unknown outcome. There were much practice deviations from the protocol. Forty-four percent (64 cases) of the management decisions were made based on the initial clinical and ultrasound findings, and another 14% (21 cases) after a repeat assessment within the next day by either a repeat scan or serial serum hCG over one day. Among them, two of the 29 operated for suspected ectopic pregnancy were not ectopic (7%) and two of the 56 thought not to be ectopic, turned out to be ectopic (4%) (p < 10(-8)). Six percent (8 cases) defaulted after the initial assessments and one of them was found to be ectopic subsequently. Thirty percent (43 cases) adhered to the protocol. They had serial serum hCG done over two days. Seven of them requiring further repeats of serial serum hCG before management decisions were made. Four patients who were operated on were confirmed ectopic and 39 patients not operated on were not ectopic. Three percent (5 cases) were managed by serial hCG over 3 to 5 days and another 3% (4 cases) by repeating scan over one to two weeks without serial hCG. None of these was ectopic. The percentage change of hCG levels over two days gave indications of the likely diagnosis. CONCLUSION Adhering to a protocol utilising the principle of ultrasound scan, serial hCGs and selective repeat ultrasound scans are highly recommended for the diagnosis of ectopic pregnancy. Any deviation from protocol is dangerous, with a 4% risk of missing an ectopic and a 7% risk of unnecessary operation for suspected ectopic pregnancy.
Collapse
Affiliation(s)
- G H Koh
- Department of Reproductive Medicine, KK Women's and Children's Hospital, Singapore
| | | |
Collapse
|
35
|
Yeong CT, Tan KH, Tee CS, Yeo GS. Optimising management of stillbirths in modern Singapore. Singapore Med J 1997; 38:317-20. [PMID: 9364882] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
OBJECTIVE To conduct a critical analysis of stillbirths in Kandang Kerbau Hospital with emphasis on epidemiological factors, related causes and investigation strategies. DESIGN A prospective study. SETTING Kandang Kerbau Hospital. PATIENTS Case records containing antenatal and post-partum details of all 136 stillbirths were obtained from the medical records office and reviewed by 3 obstetricians. Epidemiological data, antenatal history, intrapartum progress, post-partum investigation, post-mortem findings (where applicable) were reviewed and recorded. RESULTS The incidence of stillbirths was 4.48/ 1,000 in 1994. 73.1% of the stillbirths were macerated. Significantly higher stillbirth rates were noted in the Malays and unbooked or late booking cases. The causes of stillbirths were unexplained in 29.4%. Fetal anomalies constituted 18.4%, followed by asphyxia, abruptio, and cord accidents. Maternal obstetrical problems contributed to the rest. CONCLUSION A comprehensive management strategy to reduce stillbirths include community and patient education, early or shared antenatal care, careful prenatal surveillance, optimum investigations as well as a careful audit with adequate bereavement and counselling.
Collapse
Affiliation(s)
- C T Yeong
- Department of Maternal Fetal Medicine, Kandang Kerbau Women's and Children's Hospital, Singapore
| | | | | | | |
Collapse
|
36
|
Chen LH, Yeong CT, Yeo GS. Three cases of fatal pulmonary embolism in obstetrics. Ann Acad Med Singap 1997; 26:356-9. [PMID: 9285032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
We conducted a retrospective analysis of maternal deaths in our hospital from January 1992 to December 1995. Cases of fatal pulmonary embolism were identified and analysed with respect to their past history, antenatal and peripartum progress, clinical presentation and investigation. There were 7 maternal deaths during this period and autopsies were performed in all cases. Pulmonary embolism was the leading cause of maternal mortality, responsible for 3 deaths. The incidence of fatal pulmonary embolism was 4.9 per 100,000 maternities. One case occurred antepartum and 2 occurred postpartum. The antepartum case occurred after a period of immobilisation, and both postpartum cases occurred after emergency Caesarean sections. Dyspnoea and sudden cardiovascular collapse were the commonest presentations. Electrocardiograph and arterial blood gases were abnormal in both patients in whom the tests were performed. Death occurred within 11 hours of presentation of symptoms in all 3 cases. Pulmonary embolism was more common among our population than previously reported, and was the leading cause of maternal mortality in our institution over the last 4 years. Immobilisation and Caesarean section were the major risk factors. Identification of high risk situation, antithrombotic prophylaxis and a high degree of suspicion were the key to reducing the incidence of fatal pulmonary embolism in obstetric patients.
Collapse
Affiliation(s)
- L H Chen
- Department of Maternal Fetal Medicine, K K Women's and Children's Hospital, Singapore
| | | | | |
Collapse
|
37
|
Chow BH, Loh SF, Yan YL, Ang HK, Yeo GS. Holoprosencephaly and chromosomal anomalies. Singapore Med J 1996; 37:394-7. [PMID: 8993141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Holoprosencephaly is a rare cerebral malformation resulting from failure or incomplete cleavage of the forebrain. The sonographic diagnosis consists of monoventricle, fused thalami and absent cavum septum pellucidi. Chromosomal anomalies, diabetes mellitus, alcohol, autosomal recessive inheritance and toxins have been implicated. We describe seven cases of holoprosencephaly diagnosed in the antenatal and postnatal periods. The chromosomal anomalies included trisomy 13, triploidy, trisomy 13 with an unbalanced 13; 14 translocation and isochromosome of the long arm of 18. The clinicopathological findings and chromosomal anomalies are correlated.
Collapse
Affiliation(s)
- B H Chow
- Department of Maternal Fetal Medicine, Kandang Kerbau Hospital, Singapore
| | | | | | | | | |
Collapse
|
38
|
Abstract
This study was done to determine if impaired glucose tolerance in pregnancy was associated with increased maternal and neonatal morbidity and if so, whether the increased morbidity was due to the confounding factors of increased maternal age and maternal obesity. It was a retrospective analysis to compare 944 women with impaired glucose tolerance (IGT) in pregnancy with 10,065 women without abnormal glucose tolerance. The incidence of impaired glucose tolerance in pregnancy was 8.6% in this study. Even when maternal age and obesity were excluded, the IGT group had significantly higher risks of labour induction (relative risk, RR, 1.15); Caesarean section (RR: overall 1.43, elective 1.72, emergency 1.31); Caesarean section for dystocia/no progress (RR 1.60); macrosomia (RR 1.69, 1.76, 1.61 for birth-weight > = 97th, 95th, 90th percentiles respectively) and shoulder dystocia (RR 2.84) when compared to the nondiabetics (NDM). The risks of hypertensive disease (RR 1.22) and Caesarean section for fetal distress/thick meconium-stained liquor (RR 1.53) were also higher in the IGT group but these increases were not statistically significant when maternal age and obesity were excluded. There was no significant difference in the rates of low Apgar scores at 1 and 5 minutes between the 2 groups.
Collapse
Affiliation(s)
- Y Y Tan
- Department of Maternal and Fetal Medicine, Kandang Kerbau Hospital, Singapore
| | | |
Collapse
|
39
|
Lai FM, Yeo GS. Reference charts of foetal biometry in Asians. Singapore Med J 1995; 36:628-36. [PMID: 8781636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
OBJECTIVES To construct reference ranges for foetal biometry measurements of biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), femur length (FL), humerus length (HL) and mandible length (ML) for the Asian population in Singapore. DESIGN A prospective, cross-sectional study. SETTING The obstetric ultrasound services and the labour ward of the department of Obstetrics and Gynaecology in Singapore General Hospital. SUBJECTS The foetuses of 6,374 women whose delivery date was within 2 weeks of their estimated date of delivery (EDD) as calculated from the last menstrual period. METHOD During the period August 1, 1989 and December 31, 1993, 17,005 obstetric ultrasound scans were retrieved from the computerised database. These ultrasound scans were cross-referenced with the delivery database and the earliest ultrasound scan of 6,374 women who delivered within 2 weeks of their EDD were retrieved for analysis. Different growth models were fitted using regression analysis to estimate the mean and standard deviations as functions of gestational age. Centiles were then derived after confirming a normal distribution of measurements at each gestation. RESULTS A total of 6,131 measurements of the BPD, 6,117 measurements of the HC, 6,017 measurements of the AC, 6,078 measurements of the FL, 2,863 measurements of the HL and 2,029 measurements of the ML were obtained. Regression analysis using the linear-cubic formula was used to model the mean values; a separate linear regression analysis was used to model the standard deviations. CONCLUSION These are the regressed reference charts from 6,374 Asian foetuses using parametric analysis of cross-sectional data. The authors encourage their use in Asian foetuses.
Collapse
Affiliation(s)
- F M Lai
- Department of Maternal-Foetal Medicine, Kandang Kerbau Hospital, Singapore
| | | |
Collapse
|
40
|
Yeo GS, Tan KH, Liu TC. The role of discriminant functions in screening for beta-thalassaemia traits during pregnancy. Singapore Med J 1995; 36:615-8. [PMID: 8781633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
INTRODUCTION The mean red cell volume (MCV) has been shown to be useful in a 2-stage screening process for beta-thalassaemia traits among pregnant women though associated with a large number of false positive results. We tested prospectively the ability of 5 discriminant functions (DF), (England & Fraser, Shine & Lal, Mentzer, Srivistava and Klee et al) to reduce the number of false positives when used as additional screening determinants for beta-thalassaemia in antenatal patients with red cell microcytosis. METHODS The diagnostic performance of each DF was compared in 493 patients with microcytosis and known beta-thalassaemia status. Truth table analysis and Receiver Operation Characteristic curves for each function were determined. RESULTS 11.4% of the patients with microcytosis were diagnosed to have beta-thalassaemia traits. DFs incorporating the red cell indices: haemoglobin or total red cell count are unsuitable during pregnancy. Shine & Lal's index [(0.01 x MCH x (< MCV)2] reduced the number of people recalled for confirmatory testing by 31.1% and increased the diagnostic yield to 38.7% while maintaining a negative predictive value for the test of 0.993. CONCLUSION We conclude that a 3-stage screening process for beta-thalassaemia among pregnant women in Singapore involving the MCV, Shine & Lal's index and a confirmatory test to be both valid and cost-effective.
Collapse
Affiliation(s)
- G S Yeo
- Department of Maternal-Fetal Medicine, Kandang Kerbau Hospital, Singapore
| | | | | |
Collapse
|
41
|
Yeo GS, Lim YW, Yeong CT, Tan TC. An analysis of risk factors for the prediction of shoulder dystocia in 16,471 consecutive births. Ann Acad Med Singap 1995; 24:836-40. [PMID: 8838991] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
This paper is a univariate analysis of the demographic, antepartum and intrapartum risk factors in a series of 16,471 consecutive deliveries in a tertiary obstetric and gynaecological unit in Singapore. In total, 12,229 term vaginal cephalic deliveries with 77 cases of shoulder dystocia were entered into the study for analysis. The incidence of shoulder dystocia was found to be 0.63% of all term vaginal cephalic deliveries. There is a direct relationship between increasing infant birthweight and incidence of shoulder dystocia. The critical birthweight for the prediction of shoulder dystocia is 3600 g. In order of decreasing relative risks, the factors which appear to be predictive of shoulder dystocia are a birthweight in excess of 3600 g, diabetes in pregnancy, lower social class, of Indian origin, maternal weight in excess of 70 kg, parity more than 4, and the use of oxytocics during labour. The local birthweight distribution is very different from the West. A policy for elective caesarean section for birthweights in excess of 4000 g (97% tile) would prevent 44% of shoulder dystocias, increase the caesarean section rate by 2% and half the perinatal mortality among births with shoulder dystocia.
Collapse
Affiliation(s)
- G S Yeo
- Department of Maternal Fetal Medicine, Kandang Kerbau Hospital, Singapore
| | | | | | | |
Collapse
|
42
|
Chen LH, Tan KH, Yeo GS. A ten-year review of uterine rupture in modern obstetric practice. Ann Acad Med Singap 1995; 24:830-5. [PMID: 8838990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
The aim of this paper is to determine the antecedent factors, clinical presentation, complications and management of uterine rupture in the context of modern obstetric practice in Singapore. We conducted a retrospective study of 26 proven cases of uterine rupture in Kandang Kerbau Hospital, Singapore between January 1983 to December 1992. These cases were analysed with regards to their past history, clinical presentation, complications, management and outcome. The incidence of uterine rupture was 1 in 6331 deliveries. The ratio of cases with scarred uteri against those with unscarred uteri was 3:1. The commonest antecedent factor was previous lower segment caesarean section for the scarred group and cephalo-pelvic disproportion in the unscarred group. Overall, 46.2% of the patients had augmentation with oxytocin. The major clinical presentations were abnormal cardiotocogram (25%) and blood-stained amniotic fluid (20%) in the scarred group, and postpartum haemorrhage (50%) and shock (33%) in the unscarred group. Repair of the uterus with or without tubal ligation was performed in 95% of the patients with scarred uteri, whereas 67% of the patients with unscarred uteri underwent total abdominal hysterectomy with or without salpingo-oophorectomy. There was 1 (3.8%) maternal death. Maternal morbidity included bladder injuries, broad ligament haematoma, disseminated intravascular coagulation and gastrointestinal bleeding. The overall incidence of fetal loss was 7.4%. When compared to a previous study on uterine rupture in the same hospital, there was an improvement in obstetric performance.
Collapse
Affiliation(s)
- L H Chen
- Department of Maternal Fetal Medicine, Kandang Kerbau Hospital, Singapore
| | | | | |
Collapse
|
43
|
Low JJ, Yeo GS. Eclampsia--are we doing enough? Singapore Med J 1995; 36:505-9. [PMID: 8882535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
OBJECTIVES This paper reviews the cases of eclampsia managed at the Kandang Kerbau Hospital with respect to incidence, management, maternal and perinatal outcome. METHOD A retrospective analysis of eclampsia occurring over a 4-year period from January 1990 to December 1993. RESULTS There were 27 cases of eclampsia among 59,599 deliveries during the study period, giving an overall incidence of 45.3 per 100,000 deliveries. Sixteen patients were nulliparous and the mean age was 29 years. Two-thirds of the cohort were booked patients and more than half of the cohort (55.6%) had their first seizure despite being in hospital. The majority (86.2%) of all seizures recorded occurred in the antepartum and intrapartum period. Eleven of the patients (40.7%) were asymptomatic prior to the first fit while headache was the commonest symptom of impending eclampsia in the remainder. Fifteen patients (55.6%) had significant proteinuria and this was associated with significant neonatal morbidity. The mean gestational age was 35.9 weeks and the mean birth weight was 2,328g. Major areas of substandard management included failure to administer anticonvulsant prophylaxis and antihypertensive agents when indicated, failure to assess for proteinuria, and failure to closely monitor the hypertensive and proteinuric patient. Seven patients developed convulsions despite anticonvulsant prophylaxis. Twenty-four patients were delivered by Caesarean section. There were 26 live born infants (singletons) and one abortus. There was no perinatal mortality. Neonatal morbidity was frequent and attributable to prematurity (51.9%) and birth asphyxia (29.6%). The majority of infants were well neurologically on long term follow-up. There was no maternal mortality but significant morbidity was present in 8 patients (29.6%). High uric acid levels were associated with intrauterine death, prematurity and intrauterine growth retardation. Seven patients remained hypertensive on follow-up. Residual neurological deficits persisted in 3 patients. CONCLUSIONS The incidence of eclampsia at Kandang Kerbau Hospital shows an unsteady decline over the past 4 years. It carries significant foetal mortality (3.7%) as well as neonatal (74.1%) and maternal (29.6%) morbidity. The observation that neither the occurrence of antenatal office visits nor hospitalisation prevents eclampsia, and that substandard management was identified in most of the cases (77.8%) shows that there is no room for complacency and that more needs to be done. Improvement in patient assessment, institution of appropriate preventive therapy, a high index of suspicion even in apparently low-risk patients coupled with a disease notification system and regular audit may be the key strategies to reduce the incidence of this dreaded obstetric complication.
Collapse
Affiliation(s)
- J J Low
- Department of Oncology and Urogynaecology, Kandang Kerbau Hospital, Singapore
| | | |
Collapse
|
44
|
Abstract
This study was done to test the clinical impression that the result of the oral glucose tolerance test could be used to predict which patients with gestational diabetes did not need insulin therapy. If this was true, a full blood sugar profile assessment could be avoided in many of these women. The second analysis was to test the clinical impression that the fasting glucose level was the best predictor of insulin requirement in women with gestational diabetes. The results of the study showed that none of the 3 readings of the oral glucose tolerance test could be used to predict reliably which patients did not need insulin therapy. Hence, blood sugar profile assessment of all patients with gestational diabetes is still necessary. The receiver-operator characteristic curves also showed that the 2-hour postload glucose level during the 75 g load glucose tolerance test was a better predictor of insulin requirement than the fasting glucose level.
Collapse
Affiliation(s)
- Y Y Tan
- Department of Maternal Fetal Medicine, Kandang Kerbau Hospital, Singapore
| | | | | |
Collapse
|
45
|
Abstract
Second trimester assessment of uterine blood flow has been advocated as a predictor of subsequent adverse perinatal outcome. The reproducibility of uterine artery resistance index, as assessed using colour Doppler imaging, was investigated. Two observers, both of whom were experienced in colour Doppler assessment of uterine artery flow velocity waveforms, performed the measurements. One-way analysis of variance was used to evaluate intraobserver variability and the limits of agreement method was used to determine the 95% prediction interval for interobserver differences. The intraobserver standard deviation was small for both observers. The limits of agreement for interobserver differences were wide (-0.24, 0.16), similar in magnitude to those reported by other workers who assessed the uterine vessel using continuous wave Doppler. The poor reproducibility of the resistance index suggests that second trimester Doppler assessment of uterine artery flow velocity waveforms may be better described using other semiquantitative methods such as the presence or absence of a diastolic notch.
Collapse
Affiliation(s)
- Y L Yan
- Department of Maternal Fetal Medicine, Kandang Kerbau Hospital, Singapore
| | | | | | | |
Collapse
|
46
|
Tan SA, Cheng HH, Yeo GS. Birth defects--the state of awareness amongst mothers. Singapore Med J 1994; 35:471-4. [PMID: 7701364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Birth defects have in recent years become the major cause of perinatal morbidity and mortality. The incidence of birth defects is between 2% to 6% of all live births. However, from a survey carried out in Singapore General Hospital (SGH), the majority of mothers enter pregnancy without realising the risks that they or their offspring may face. Only 20% to 25% of mothers were aware of the actual incidence of birth defects, and only 2.5%-10% knew that the risk of Down Syndrome (DS) increases with maternal age. However, the use of ultrasound is now well accepted and is considered a necessary investigation by 90% of the mothers surveyed.
Collapse
Affiliation(s)
- S A Tan
- Department of Obstetrics & Gynaecology, Singapore General Hospital
| | | | | |
Collapse
|
47
|
Yeo GS, Chan WB, Lun KC, Lai FM. Racial differences in fetal morphometry in Singapore. Ann Acad Med Singap 1994; 23:371-6. [PMID: 7944253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
A systematic collection of fetal morphometric measurements was started seven years ago in 1987 with the prospective entry of data into personal computer-based stations in the Department of Obstetrics and Gynaecology, Singapore General Hospital. A cross-sectional study was done, comparing 2392 Chinese fetuses with 2117 Malay fetuses and 459 Indian fetuses from 18 to 40 weeks. The mean values of the head circumference (HC), abdominal circumference (AC) and femur length (FL) of the 3 ethnic groups were analysed. There were no statistical significant differences in the head circumference and abdominal circumference of Chinese, Malay and Indian fetuses in Singapore. The Chinese and Malay fetal femur length appeared similar but were apparently shorter than the Indian femur length. Nomograms of head circumference, abdominal circumference and femur length were constructed for application to fetuses of all 3 ethnic groups.
Collapse
Affiliation(s)
- G S Yeo
- Department of Maternal Fetal Medicine, Kandang Kerbau Hospital, Singapore
| | | | | | | |
Collapse
|
48
|
Yeo GS, Tan KH, Liu TC. Screening for beta thalassaemia and HbE traits with the mean red cell volume in pregnant women. Ann Acad Med Singap 1994; 23:363-6. [PMID: 7944251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Both beta thalassaemia and HbE disease are microcytic red cell disorders. Pregnancy however induces macrocytosis which makes screening with the mean cell volume (MCV) difficult in antenatal patients. In addition, population screening for HbE has not been widely reported in the literature and the screening criteria for beta thalassaemia may not necessarily apply. A study of the value of the MCV for routine screening for both beta thalassaemia and HbE traits in 3696 antenatal patients of different gestational ages was carried out. All patients with an MCV < or = 80 fL received confirmatory tests for haemoglobinopathies. The MCV rose by only 2.0% in pregnancy. A total of 494 patients (13.4% of the general population) had an MCV < or = 80 fL. Of these microcytic patients, 11.3% (56) and 4.7% (23) were eventually confirmed to have beta thalassaemia and HbE traits respectively. The mean MCV for the 3696 antenatal patients was 87.8 fL (SD 7.5) compared to patients with beta thalassaemia and HbE traits, which were 67.5 fL (SD 4.5) and 75.7 fL (SD 4.1). HbE traits were less microcytic than beta thalassaemia traits and overlapped significantly with the general population. Beta thalassaemia trait and HbE trait detected by this screening method constituted 1.52% and 0.62% respectively of the total antenatal population screened. The MCV remains a valid screening parameter in pregnancy for beta thalassaemia trait. As for HbE trait, applying a discriminant value of 80 fL to the MCV in the population screening would miss a significant proportion of the HbE traits.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- G S Yeo
- Maternal Fetal Medicine Department, Kandang Kerbau Hospital, Singapore
| | | | | |
Collapse
|
49
|
Tan SA, Yeo GS, Cheng HH. Birth defects--the state of awareness. Singapore Med J 1994; 35:67-70. [PMID: 8009285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
As doctors and nurses are the primary sources of medical information, a simple survey was conducted in 1992 among doctors and nurses to determine their level of awareness of the incidence of and risk of having an abnormal as well as their knowledge of the use of ultrasound in pregnancy. Only 10% of doctors and 23% of nurses were aware that the general risk of having an abnormal baby is greater than 1%. Only 37% and 17% of doctors and nurses respectively were aware that the best time to screen for structural abnormalities was indeed at approximately 20 weeks gestation.
Collapse
Affiliation(s)
- S A Tan
- Department of Obstetrics & Gynaecology, Singapore General Hospital
| | | | | |
Collapse
|
50
|
Yeo GS, Ali AA. The effect of prenatal diagnosis on the incidence of Down syndrome livebirths in the Singapore General Hospital. Singapore Med J 1992; 33:38-41. [PMID: 1534635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
During a 3-year-period between January 1988 and December 1990, there were 12 Down Syndrome (DS) livebirths out of 13,794 livebirths at the Department of Obstetrics and Gynaecology, Singapore General Hospital, giving an incidence of 1 in 1,150 livebirths or 0.87 per thousand. There were 1569 mothers who were 35 years or older at the expected date of delivery (EDD) and 5 of these 12 DS livebirths were from these older mothers. Although only 11.5% of all mothers were 35 years or more, as a group, these older mothers contributed to 42% of the DS livebirths. There were 5 DS fetuses diagnosed prenatally and 4 were aborted electively. The fifth DS fetus which was diagnosed prenatally was allowed to continue to term because of the mother's religious objection to an induced abortion. The failure to offer prenatal diagnosis and selective procreation to all mothers 35 years or older had resulted in 4 unnecessary DS births, reducing our DS detection rate by a factor of 33%. All these 4 cases were booked late for antenatal care.
Collapse
Affiliation(s)
- G S Yeo
- Department of Obstetrics & Gynaecology, Singapore General Hospital
| | | |
Collapse
|